>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Compass Minerals (CMP) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $15
    • CRISPR Therapeutics (CRSP) upgraded to Hold from Sell at TD Cowen; tgt $35
    • Mercury General (MCY) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $80
    • Upstart (UPST) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $105
    • Upstart (UPST) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $79
  • Downgrades:
    • Axcelis Tech (ACLS) downgraded to Mkt Perform from Outperform at William Blair
    • Fluence (FLNC) downgraded to Peer Perform from Outperform at Wolfe Research
    • Fluence (FLNC) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $6.50
    • Fluence (FLNC) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $7
    • Fluence (FLNC) downgraded to Neutral from Buy at UBS; tgt lowered to $8
    • On (ONON) downgraded to Neutral from Buy at Goldman; tgt $57
    • PPG Industries (PPG) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $115
    • STAAR Surgical (STAA) downgraded to Mkt Perform from Outperform at William Blair
    • STAAR Surgical (STAA) downgraded to Neutral from Buy at BTIG Research
    • STAAR Surgical (STAA) downgraded to Neutral from Outperform at Mizuho; tgt lowered to $17
    • Tempus AI (TEM) downgraded to Mkt Perform from Outperform at William Blair
    • Third Harmonic Bio (THRD) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $5
  • Others:
    • AstraZeneca (AZN) initiated with an Overweight at Morgan Stanley
    • Blaize Holdings (BZAI) initiated with a Buy at DA Davidson; tgt $10
    • CleanSpark (CLSK) initiated with a Buy at Needham; tgt $20
    • Exodus Movement (EXOD) initiated with a Buy at Compass Point; tgt $70
    • GlaxoSmithKline (GSK) initiated with an Equal-Weight at Morgan Stanley
    • Lucid Group (LCID) initiated with a Buy at The Benchmark Company; tgt $5
    • Novartis AG (NVS) initiated with an Underweight at Morgan Stanley
    • Novo Nordisk A/S (NVO) initiated with an Equal-Weight at Morgan Stanley
    • Ralph Lauren (RL) initiated with a Buy at Needham; tgt $310
    • Rapid Micro Biosystems (RPID) initiated with an Overweight at KeyBanc Capital Markets; tgt $8
    • Roche Hldg (RHHBY) initiated with an Equal-Weight at Morgan Stanley
    • Tesla (TSLA) initiated with a Buy at The Benchmark Company; tgt $475
    • V.F. Corp (VFC) initiated with a Buy at Needham; tgt $28